Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Arnold S. Freedman. (1996) Cell Surface Antigens in Leukemias and Lymphomas. Cancer Investigation 14:3, pages 252-276.
Read now
Read now
Christian Sperling, Thomas Buuchner, Ursula Creutzig, Jourg Ritter, Jochen Harbott, Christa Fonatsch, Christina Sauerland, Marco Mielcarek, Georg Maschmeyer, Helmut Louffler & Wolf Dieter Ludwig. (1995) Clinical, Morphologic, Cytogenetic and Prognostic Implications of CD34 Expression in Childhood and Adult de novo AML. Leukemia & Lymphoma 17:5-6, pages 417-426.
Read now
Read now
Articles from other publishers (23)
Veronica J. Lyons & Dimitri Pappas. (2019) Affinity separation and subsequent terminal differentiation of acute myeloid leukemia cells using the human transferrin receptor (CD71) as a capture target. The Analyst 144:10, pages 3369-3380.
Crossref
Crossref
Wendelien Zeijlemaker, Angèle Kelder, Rolf Wouters, Peter J.M. Valk, Birgit I. Witte, Jacqueline Cloos, Gert J. Ossenkoppele & Gerrit J. Schuurhuis. (2015)
Absence of leukaemic CD34
+
cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy deciphered
. British Journal of Haematology 171:2, pages 227-238.
Crossref
Crossref
Tanja Schneider, Anne Flörcken, Anju Singh, Seval Türkmen, Thomas Burmeister, Ioannis Anagnostopoulos, Antonio Pezzutto, Bernd Dörken & Jörg Westermann. (2015) Flow cytometric maturity score as a novel prognostic parameter in patients with acute myeloid leukemia. Annals of Hematology 94:8, pages 1337-1345.
Crossref
Crossref
Teruyuki Kajiume, Nobutsune Ishikawa, Norioki Ohno, Yasuhiko Sera, Syuhei Karakawa & Masao Kobayashi. (2012) Expression of the polycomb group gene <i>Bmi</i>1 does not affect the prognosis of pediatric acute lymphoblastic leukemia. Stem Cell Discovery 02:02, pages 25-30.
Crossref
Crossref
Jia Rao, Duo-Rong Xu, Fei-Meng Zheng, Zi-Jie Long, Sheng-Shan Huang, Xing Wu, Wei-Hua Zhou, Ren-Wei Huang & Quentin Liu. (2011) Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells. Journal of Translational Medicine 9:1.
Crossref
Crossref
C. Rollig, C. Thiede, M. Gramatzki, W. Aulitzky, H. Bodenstein, M. Bornhauser, U. Platzbecker, R. Stuhlmann, U. Schuler, S. Soucek, M. Kramer, B. Mohr, U. Oelschlaegel, F. Stolzel, M. von Bonin, M. Wermke, H. Wandt, G. Ehninger & M. Schaich. (2010) A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial. Blood 116:6, pages 971-978.
Crossref
Crossref
Mariette Matondo, Marie-Pierre Bousquet-Dubouch, Nathalie Gallay, Sandrine Uttenweiler-Joseph, Christian Recher, Bernard Payrastre, Stéphane Manenti, Bernard Monsarrat & Odile Burlet-Schiltz. (2010) Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: A correlation with the proteasome status. Leukemia Research 34:4, pages 498-506.
Crossref
Crossref
Emmanuelle Tavernier-Tardy, Jérôme Cornillon, Lydia Campos, Pascale Flandrin, Amélie Duval, Nathalie Nadal & Denis Guyotat. (2009) Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia. Leukemia Research 33:6, pages 764-768.
Crossref
Crossref
Fred G. Behm. 2010. Childhood Leukemias. Childhood Leukemias
150
209
.
Roel G. W. VerhaakChantal S. GoudswaardWim van PuttenMaarten A. BijlMathijs A. SandersWendy HugensAndré G. UitterlindenClaudia A. J. ErpelinckRuud DelwelBob LöwenbergPeter J. M. Valk. (2005) Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood 106:12, pages 3747-3754.
Crossref
Crossref
Hong Chang, Fariha Salma, Qin-long Yi, Bruce Patterson, Bill Brien & Mark D Minden. (2004) Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia. Leukemia Research 28:1, pages 43-48.
Crossref
Crossref
D Raspadori, D Damiani, M Lenoci, D Rondelli, N Testoni, G Nardi, C Sestigiani, C Mariotti, S Birtolo, M Tozzi & F Lauria. (2001) CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia 15:8, pages 1161-1164.
Crossref
Crossref
Edward G Weir & Michael J Borowitz. (2001) Flow cytometry in the diagnosis of acute leukemia. Seminars in Hematology 38:2, pages 124-138.
Crossref
Crossref
Yoshinobu Kanda, Tamae Hamaki, Rie Yamamoto, Aki Chizuka, Miyuki Suguro, Tomohiro Matsuyama, Naoki Takezako, Akiyoshi Miwa, Masahiro Kami, Hisamaru Hirai & Atsushi Togawa. (2000) The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia. Cancer 88:11, pages 2529-2533.
Crossref
Crossref
Fred G. Behm. (1999) Diagnosis of Childhood Acute Myeloid Leukemia. Clinics in Laboratory Medicine 19:1, pages 187-238.
Crossref
Crossref
Katsunori Kyoda, Shinobu Nakamura, Noritaka Hattori, Minoru Takeshima, Kiku Nakamura, Hiroyasu Kaya, Sadaya Matano, Hirokazu Okumura, Masatoshi Kanno, Shigeki Ohtake & Tamotsu Matsuda. (1998) Lack of prognostic significance of CD34 expression in adult AML when FAB M0 and M3 are excluded. American Journal of Hematology 57:3, pages 265-266.
Crossref
Crossref
C. Darrell JenningsKenneth A. Foon. (1997) Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy. Blood 90:8, pages 2863-2892.
Crossref
Crossref
Donatella Raspadori, Francesco Lauria, Maria Alessandra Ventura, Damiano Rondelli, Giuseppe Visani, Antonio de Vivo & Sante Tura. (1997) Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: Analysis of 141 cases. Leukemia Research 21:7, pages 603-607.
Crossref
Crossref
Bernhard Wörmann, Doris Grove, Michael Falk, Stefan Könemann, Yvonne Markloff, Silvia Toepker, Axel Heyll, Carlo Aul, Jörg Ritter, Thomas Büchner, Wolfgang Hiddemann, Leon W. M. M. Terstappen & Frank Griesinger. 1996. Acute Leukemias V. Acute Leukemias V
506
513
.
H.T. Hassan & M. Freund. (1995) Human stem cell factor protects CD34 positive human myeloid leukaemia cells from chemotherapy-induced apoptosis. European Journal of Cancer 31:11, pages 1883-1884.
Crossref
Crossref
H. T. Hassan, E. Petershofen, E. Lux, C. Fonatsch, G. Heil & M. Freund. (1995) Establishment and characterization of a novel CD34-positive human myeloid leukemia cell line: MHH225 growing in serum-free culture. Annals of Hematology 71:3, pages 111-117.
Crossref
Crossref
Francesco Lauria, Donatella Raspadori, Maria Alessandra Ventura, Damiano Rondelli, Nicoletta Testoni, Patrizia Tosi, Maria Rosa Motta, Sante Tura, Mariagrazia Michieli & Daniela Damiani. (2008) The presence of lymphoid‐associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance. STEM CELLS 13:4, pages 428-434.
Crossref
Crossref
Gerald J. Spangrude, Ph.D. (1994) BIOLOGICAL AND CLINICAL ASPECTS OF HEMATOPOIETIC STEM CELLS. Annual Review of Medicine 45:1, pages 93-104.
Crossref
Crossref